JAN 14, 2020 8:00 AM PST

CiPA initiative and validation of high-throughput methods to characterize compound effects in human iPSC-derived cardiomyocytes



DATE: January 14, 2020

TIME:  8:00 am PST, 4:00 pm GMT, 5:00 pm CET


Drug-induced QT interval prolongation and Torsades de Pointes (TdP) arrhythmias are the leading causes for drug withdrawals from market and compound attrition during drug development. To assess potential cardiotoxicity of compounds, Comprehensive in vitro Proarrhythmia Assay (CiPA) is the new cardiac safety testing paradigm that includes in vitro assays using human induced pluripotent stem cell derived cardiomyocytes (hiPSC-CM). To adopt this paradigm, we developed a high-throughput hiPSC-CM assay using calcium-sensitive dyes that exhibit fast kinetic fluorescence detected by the high-speed fluorescence imaging platform, the FLIPR® Penta High-Throughput Cellular Screening System.

In this webinar, we will show data on evaluated concentration-dependent responses of 28 pharmacological agents linked to low, intermediate, and high TdP risk categories. Compound-induced proarrhythmic effects such as changes in beating rate and durations of these 28 agents were quantified and reported by monitoring changes in intracellular Ca2+ oscillations. Characterization of calcium oscillations allowed us to evaluate complex waveforms and events. In addition to changes in peak frequency and amplitude, we observed compound-induced proarrhythmic effects, peak prolongations, as well as increased complexity of patterns and appearance of secondary peaks at concentrations that correlated to clinically-relevant concentrations of QT prolongation and TdP arrhythmias. We characterized waveform irregularities using ScreenWorks® Peak Pro 2 software to obtain more than 20 dose-dependent readouts. Moreover, we assessed cellular and mitochondrial toxicity of these 28 compounds in the follow-up assay using the ImageXpress® Micro Confocal High-Content Imaging System to simultaneously monitor acute & chronic dosing effects of structural cardiotoxicity with multiple toxicity indicators. Taken together, we demonstrate that our high-throughput assay can provide an in vitro drug-induced proarrhythmia assessment as part of the cardiac safety paradigm encouraged by the CiPA initiative, and strengthens pharmacological safety profiles of drug candidates.


Learning Objectives:

  • Discuss the latest news on the CiPA initiative
  • Discuss how to evaluate compound induced effects on hiPSC-derived cardiomyocytes
  • Summarize new features of the FLIPR Penta System and ScreenWorks Peak Pro 2 software


Webinars will be available for unlimited on-demand viewing after live event.


LabRoots is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. By attending this webinar, you can earn 1 Continuing Education credit once you have viewed the webinar in its entirety.

Show Resources
You May Also Like
MAY 11, 2021 10:00 AM PDT
MAY 11, 2021 10:00 AM PDT
Date: May 11, 2021 Time: 10:00zm PDT Your samples are some of the most valuable assets in the laboratory. After spending countless hours on extraction and preparation, your conclusions could...
SEP 14, 2021 7:00 AM PDT
SEP 14, 2021 7:00 AM PDT
Date: September 14, 2021 Time: 7am PDT, 10am EDT, 4pm CEST A conventional thermal cycler has long been a commodity product in the lab and end-point PCR techniques can be completed almost wit...
JUN 09, 2021 7:00 AM PDT
JUN 09, 2021 7:00 AM PDT
Date: June 9, 2021 Time: 09 June 2021, 7am PDT, 10am EDT, 4pm CEST cells with dramatic implications on the validity of past cell culture related research. The fact that at least 509 cell lin...
JUL 15, 2021 9:00 AM PDT
JUL 15, 2021 9:00 AM PDT
Date: July 15, 2021 Time: 9:00am (PDT), 12:00pm (EDT) The Pisces workflow robust, easy-to-use, end-to-end multi-omics solution for highly multiplexed targeted Spatial RNA analysis. VeranomeB...
SEP 29, 2021 11:00 AM PDT
SEP 29, 2021 11:00 AM PDT
Date: Septembr 29, 2021 Time: 11:00am (PDT), 2:00pm (EDT) 3D cell models are becoming increasingly popular for studying complex biological effects, tissue functionality, and diseases. While...
SEP 17, 2021 12:00 PM CST
SEP 17, 2021 12:00 PM CST
Date: September 16, 2021 Time: 9:00pm (PDT), 12:00am (EDT) 3D cellular models like organoids and spheroids offer an opportunity to better understand complex biology in a physiologically rele...
JAN 14, 2020 8:00 AM PST

CiPA initiative and validation of high-throughput methods to characterize compound effects in human iPSC-derived cardiomyocytes


Cell Biology

Molecular Biology

Cancer Research


Cell Culture



Drug Discovery

Molecular Diagnostics

Cancer Therapeutics



Clinical Research

Gene Expression



North America55%



South America5%



Registration Source

Website Visitors62%

Email Promotions27%

WAVE Newsletter Promotion7%

Trending Newsletter Promotion1%

Client/Sponsor Promotions1%


Job Title



Research Scientist13%


Facility/Department Manager9%

Medical Laboratory Technician8%


Lab Management5%

Clinical Laboratory Scientist5%

Post Doc4%



Medical Doctor/Specialist2%


Academic Institution23%

Biotech Company11%


Clinical Laboratory7%

Research Institute6%

Contract Research Organization (Cro)6%

Pharmaceutical Company5%

Life Science Company4%


Medical Center3%


Industrial Company2%


Medical School2%


Show Resources
Loading Comments...
Show Resources